Ireland· IE-PA-EU/1/17/1235/004-005
Zejula 100 mg Film-coated tablet
A niraparib product containing niraparid tosylate monohydrate, registered in Ireland by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 14 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Niraparib is registered in 14 of 19 countries.
Countries holding a registration under ATC L01XK02 (niraparib), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 8 of them publish a price we can compare per daily dose
Niraparib · ATC L01XK02
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of niraparib costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Niraparib · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$276.18
The record
At a glance
HPRA (Ireland)- Active substance
- Niraparid tosylate monohydrate
- Manufacturer
- GlaxoSmithKline Trading Services Limited
- Country
- Ireland (IE)
- ATC code
- L01XK02
- ATC class
- Niraparib
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/17/1235/004-005
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
405 interactions on record for niraparib.
Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Niraparib · interactions on record
405 records
- 29 severe
- 376 moderate
Most severe, free to view
- CladribineL01BB04severe
- RolapitantA04AD14moderate
- LonafarnibA16AX20moderate
- DicoumarolB01AA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01XK02
Niraparib, as other registers publish it.
- IcelandZejulaGlaxoSmithKline Trading Services Limited
- FinlandZejulaGlaxoSmithKline Trading Services Limited
- FinlandZejulaGlaxoSmithKline Trading Services Limited
- NorwayZejulaGlaxoSmithKline Trading Services Limited
- DenmarkZejulaGlaxoSmithKline (Ireland)Limited
- PolandZejulaGlaxoSmithKline (Ireland) Limited
- PolandZejulaGlaxoSmithKline (Ireland) Limited
- IcelandZejulaGlaxoSmithKline Trading Services Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ff0d1152-1a85-4b9d-bd55-079b4c2e1fa9 GET /v1/drugs/ff0d1152-1a85-4b9d-bd55-079b4c2e1fa9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"L01XK02"
],
"strength": null,
"pa_number": "EU/1/17/1235/004-005",
"substances": [
"Niraparid tosylate monohydrate"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "30/05/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about niraparib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.